TrialDiabetes research and clinical practice2014

Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes.

Mikaela Sjöstrand et al.PubMed ↗Publisher ↗

No numbers read from the abstract.